Aiwen Wu

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2021 · 414 citations

D2 Gastrectomy, Surgical Oncology, Esophageal Cancer +10

Differences in gastric cancer survival between the U.S. and China

Vivian E. Strong, Aiwen Wu, Luke V. Selby et al. · Journal of Surgical Oncology · 2015 · 177 citations · Full text

Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial

Lai Xu, Xiangqian Su, Zirui He et al. · The Lancet Oncology · 2021 · 176 citations

Surgical Oncology, Superiority Trial, Colorectal Surgery +8

Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter Study

Jiaolin Zhou, Changxi Wang, Guole Lin et al. · Clinical Cancer Research · 2020 · 130 citations

Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy

Ziyu Li, Xiangyu Gao, Xinxin Peng et al. · Science Advances · 2020 · 124 citations · Full text